Artivion (AORT) Net Equity Issued and Repurchased (2010 - 2026)
Artivion's (AORT) quarterly Net Equity Issued and Repurchased came in at $1.2 million in Q1 2026, down 70.1% YoY from $4.2 million in Q1 2025, and down 63.88% on a QoQ basis from $3.5 million in Q4 2025.
Artivion (AORT) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
Artivion (AORT) has 17 years of Net Equity Issued and Repurchased data on file, last reported at $1.2 million in Q1 2026.
- Quarterly Net Equity Issued and Repurchased fell 70.1% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.1 million (up 58.96% YoY) and the FY2025 annual result came in at $13.1 million, up 128.25% from the prior year.
- Net Equity Issued and Repurchased fell to $1.2 million in Q1 2026, from $3.5 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $5.2 million in Q3 2025 to a low of $24000.0 in Q4 2022.
- A 5-year average of $1.8 million and a median of $1.2 million in 2026 frame the typical range for Net Equity Issued and Repurchased.
- Annual changes were most pronounced in 2022 — Net Equity Issued and Repurchased slumped 89.33% — and 2023, when it surged 1933.33%.
- Tracing AORT's Net Equity Issued and Repurchased over 5 years: stood at $24000.0 in 2022, then surged by 1933.33% to $488000.0 in 2023, then fell by 9.22% to $443000.0 in 2024, then jumped by 681.26% to $3.5 million in 2025, then plunged by 63.88% to $1.2 million in 2026.
- The last three Net Equity Issued and Repurchased figures came in at $1.2 million (Q1 2026), $3.5 million (Q4 2025), and $5.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Artivion | 1.36 Bn | 1.28 Bn | 80.52 Mn | 1.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.38 Mn |
| Jun 30, 2026 | 1.38 Mn |
| Mar 31, 2026 | 1.25 Mn |
| Mar 31, 2026 | 1.25 Mn |
| Dec 31, 2025 | 3.46 Mn |
| Dec 31, 2025 | 3.46 Mn |
| Sep 30, 2025 | 5.15 Mn |
| Sep 30, 2025 | 5.15 Mn |
| Jun 30, 2025 | 278,000.00 |
| Jun 30, 2025 | 278,000.00 |
| Mar 31, 2025 | 4.18 Mn |
| Mar 31, 2025 | 4.18 Mn |
| Dec 31, 2024 | 443,000.00 |
| Dec 31, 2024 | 443,000.00 |
| Sep 30, 2024 | 1.70 Mn |
| Sep 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | 59,000.00 |
| Jun 30, 2024 | 59,000.00 |
| Mar 31, 2024 | 3.53 Mn |
| Mar 31, 2024 | 3.53 Mn |